CTOs on the Move

Phreesia

www.phreesia.com

 
Leading healthcare organizations choose Phreesia to revolutionize their point of service. In medical groups of all sizes, Phreesia`s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.phreesia.com
  • 432 Park Avenue South
    New York, NY USA 10016
  • Phone: 888.654.7473

Executives

Name Title Contact Details
Ashwin Altekar
Vice President of Information Security Profile

Similar Companies

Centrix Inc.

Centrix, Inc. manufactures and sells a complete line of dental products to the dental industry. We do this through a hybrid marketing channel of both direct and dealer distributor sales.

Mpathy Medical

Mpathy Medical is a Raynham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Grand Rapids Clinical Oncology Program

Grand Rapids Clinical Oncology Program is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

Oxford Health Plans

Oxford Health Plans, Inc. is a healthcare company providing health benefit plans primarily in New York, New Jersey and Connecticut. Its product line includes its health maintenance organization plans, exclusive provider organization plans,